Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease (Q36357360)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease |
scientific article |
Statements
1 reference
Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease (English)
1 reference
Thomas Yau
1 reference
Hilda Wong
1 reference
Pierre Chan
1 reference
T J Yao
1 reference
R Pang
1 reference
T T Cheung
1 reference
S T Fan
1 reference
Ronnie T Poon
1 reference
9 March 2012
1 reference
1 reference
2384-2390
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference